Takao Itoi
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (9)
A novel plastic stent with an integrated delivery system specifically designed for endoscopic transpapillary gallbladder stenting (EGBS) was developed. The novel stent system comprises a stent body, an inner catheter, and a pushing catheter. The stent and pusher catheter are integrated, thereby making it possible to pull back the stent. Further, it fits the anatomical shape after placement in the gallbladder as it has a curved shape. The current study evaluated the feasibility and outcomes of EGBS using the novel stent. This retrospective study analyzed the clinical data of 24 consecutive patients who underwent EGBS using the novel stent between April 2023 and March 2025. The technical success rate of stent insertion was 95.8%. In the technically successful EGBS cases, the clinical success rate for acute cholecystitis was 94.7%. The early adverse event (AE) rate was 4.2%, with only one patient presenting with Mallory–Weiss syndrome. During a mean follow‐up period of 211 days, the late AE rate in the 20 patients with permanent stent placement was 10%. The late AEs included acute pancreatitis ( n = 1) and gallbladder perforation ( n = 1). Acute pancreatitis improved with stent removal, and gallbladder perforation resolved with additional percutaneous transhepatic gallbladder drainage. There were no cases of recurrent cholecystitis or stent migration during the follow‐up period. In conclusion, the newly developed stent is feasible for EGBS and can achieve good clinical outcomes.
Year:
2025
Background Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection may result in complications or may be unsuitable for tumors that are difficult to treat endoscopically. We investigated the usefulness of a newly developed endoscopic resection technique—EMR with an over‐the‐scope clip (EMR‐O)—for difficult‐to‐treat lesions. Method We retrospectively examined patients who underwent EMR‐O for colorectal tumors between September 2017 and January 2024. Patient and lesion characteristics, technical success rates, en bloc resection rates, R0 resection rates, procedure time, histopathology, and the clinical course were evaluated. Results EMR‐O was performed for 18 patients. Indications for EMR‐O included residual or recurrent lesions (seven patients; 38.9%), diverticulum lesions (five patients; 27.8%), appendiceal orifice lesions (three patients; 16.7%), T1 cancers (two patients; 11.1%), and subepithelial tumors (one patient; 5.5%). The median lesion size was 11 mm. The rates of technical success, en bloc resection, and R0 resection were 100%, 86.7%, and 86.7%. The median procedure time was 10 min. The only adverse event was diverticulitis (one patient; 5.5%). Intraoperative and delayed perforation and bleeding were not observed. The pathological resection depths were full‐thickness for three patients (16.7%), muscularis resection for four patients (22.2%), and deep submucosal resection for 11 patients (61.1%). Conclusion Although EMR‐O is limited by the target lesion size, it shortens the procedure time, prevents perforation, and avoids the need for surgery. EMR‐O may be a minimally invasive treatment option for small lesions that are difficult to treat endoscopically.
Year:
2025
Endoscopic intraductal radiofrequency ablation (ID‐RFA) can curatively treat residual intraductal lesions after endoscopic papillectomy. This study aimed to verify the tissue invasiveness of ID‐RFA using a novel RF generator and to explore its appropriate settings in an animal experiment, followed by a small clinical study. Pig liver specimens were ablated using a dedicated RF catheter and two RF generators to investigate structural differences between them and the ablation effects produced under various voltage and power settings. Appropriate settings for the novel generator were sought to provide an ablation effect equivalent to that with the recommended settings for a conventional generator. The ablation effect was also observed at various ablation times in vitro. Then we performed ID‐RFA in five patients. Each generator has a different structure, and no novel generator settings are identical to the recommended conventional generator settings. Obtaining adequate ablation requires both sufficient power and sufficient voltage. Based on the validation experiments, we concluded that the appropriate novel generator settings were 125 Vp and 30 W for 30 s. In the clinical study, good tumor ablation was obtained with no recurrence after a single ID‐RFA treatment, although the incidence of ductal stricture was relatively high. ID‐RFA for residual intraductal lesions may potentially be curative. However, excessive ablation should be avoided. To ensure safe and effective ID‐RFA, a thorough understanding of the RF generator specifications is required.
Year:
2025
Purpose: Immunotherapies have led to a paradigm shift in the treatment of hepatocellular carcinoma (HCC). Studies have revealed the single-cell catalogs of tumor-infiltrating immune cells and the trajectories of their differentiation. Nevertheless, the spatial distribution of these immune cells with distinct phenotypes in the tumor microenvironment and their clinicopathologic significance in resectable and unresectable HCCs are still largely unclear. Experimental Design: We analyzed the spatial dynamics of intratumoral CD4 and CD8 T cells and their association with B and plasma cells using 283 surgically resected HCC samples, 58 unresectable HCC samples before combined immunotherapy [atezolizumab plus bevacizumab (Atezo + Bev)], and autopsy specimens from 50 cases of advanced-stage HCC through multiplex IHC combined with transcriptomic and driver gene mutation analyses. Classification based on the spatial dynamics of T- and B-cell responses (refined immunosubtype) was developed, and its clinicopathologic significance was analyzed. Results: We found that stem-like CD4 and CD8 T cells were mainly observed in T-cell aggregates and T-cell zone of tertiary lymphoid structure (TLS). The differentiation of T follicular helper cells was associated with the development of TLS, whereas the differentiation of CXCL13-expressing CD4 T CXCL13 cells with a phenotype resembling T peripheral helper cells was associated with the development of the lymphoplasmacytic microenvironment. The refined immunosubtype could predict clinical outcomes of resectable HCC after surgery and unresectable HCC after Atezo + Bev therapy. The immune microenvironment of metastatic lesions tended to reflect those of primary lesions. Conclusions: We revealed the spatial dynamics of T- and B-cell responses in HCC, which is closely associated with the clinical outcome after surgical resection or Atezo + Bev therapy.
Year:
2024
Objective This study aimed to implement green endoscopy through the microbiological assessment of gowning techniques during endoscopy to reduce carbon emissions and separate medical waste. Methods Twenty‐five patients who performed esophagogastroduodenoscopy from March to May 2024 were included in this study. Four sections of the isolation gowns (anterior, posterior, right, and left) were cut into 2 cm 2 after endoscopy, and the rate of microbial contamination was examined using the stamp method. Results The endoscopic examination time was 8 min (6−12), and endoscopy was performed by 10 expert endoscopists, six endoscopists, and nine residents. The overall isolation gown contamination rate was 56%, with 25%, 20.8%, 20.8%, and 33.3% in the front, back, as well as right and left arms, respectively. The rates of isolation gown contamination rates in the expert endoscopists, endoscopists, and residents groups were 30%, 50%, and 77.8%, respectively, with a higher rate in the residents group. Regardless of the physician's performance, bacterial detection was consistently higher in the left arm (42.9% vs. 40% vs. 25%; p = 0.093). The detected bacteria comprised 58% Gram‐positive and 42% Gram‐negative organisms, including those from tap water used for endoscopy bacteria and obtained from the participant's skin or mouth. No pathogenic organisms were detected. Conclusions The bacteria detected in disposable gowns after gastrointestinal endoscopy were non‐pathogenic. Thus, our findings suggest that changing all personal protective equipment of respective endoscopes might not be essential. We advocate for green endoscopy to achieve sustainable development goals and reduce medical waste.
Year:
2024
The consensus‐based TOKYO criteria were proposed as a standardized reporting system for endoscopic transpapillary biliary drainage. The primary objective was to address issues arising from the inconsistent reporting of stent outcomes across studies, which has complicated the comparability and interpretation of study results. However, the original TOKYO criteria were not readily applicable to recent modalities of endoscopic biliary drainage such as biliary drainage based on endoscopic ultrasound or device‐assisted endoscopy. There are increasing opportunities for managing hilar biliary obstruction and benign biliary strictures through endoscopic drainage. Biliary ablation has been introduced to manage benign and malignant biliary strictures. In addition, the prolonged survival times of cancer patients have increased the importance of evaluating overall outcomes during the period requiring endoscopic biliary drainage rather than solely focusing on the patency of the initial stent. Recognizing these unmet needs, a committee has been established within the Japan Gastroenterological Endoscopy Society to revise the TOKYO criteria for current clinical practice. The revised criteria propose not only common reporting items for endoscopic biliary drainage overall, but also items specific to various conditions and interventions. The term “stent‐demanding time” has been defined to encompass the entire duration of endoscopic biliary drainage, during which the overall stent‐related outcomes are evaluated. The revised TOKYO criteria 2024 are expected to facilitate the design and reporting of clinical studies, providing a goal‐oriented approach to the evaluation of endoscopic biliary drainage.
Year:
2024
Objective Few reports have explored the application of urinary trypsinogen‐2 measurement in the early diagnosis of post‐endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis, and none have demonstrated the benefits of noninvasive testing. This study aimed to evaluate the clinical application of the rapid urinary trypsinogen‐2 dipstick test (Nipro, Japan) compared with serum amylase and lipase levels for the early diagnosis of post‐ERCP pancreatitis (PEP). Methods A total of 100 consecutive patients (54 men and 46 women) who were admitted and underwent ERCP at Tokyo Medical University Hospital from August 2021 to December 2021 were recruited. All patients underwent rapid urinary trypsinogen‐2 measurement using the dipstick test before and after ERCP. Measurements were taken 24 h before ERCP for pre‐ERCP and 1–4 h after ERCP for post‐ERCP. Additionally, serum amylase and lipase levels were measured at 8:00 a.m. of the day after ERCP (at least 8 h after ERCP), and their diagnostic abilities for PEP were compared and evaluated. Results PEP occurred in 5/100 patients (5%). The sensitivity, specificity, positive predictive value, and negative predictive value of the dipstick test for diagnosing PEP were 100%, 83.2%, 23.8%, and 100%, respectively. These results were comparable to the diagnostic performance of serum amylase and lipase levels at 8:00 a.m. on the day after ERCP (at least 8 h after ERCP). However, false positives must be considered. Conclusion The dipstick test may be useful in clinical practice as a noninvasive screening test for the early prediction of PEP.
Year:
2024
Background Endoscopic ultrasound‐guided tissue acquisition is vital for diagnosing pancreatic and peridigestive tract lesions. A new three‐prong asymmetry tip needle has been developed for this procedure. In this study, we retrospectively assessed the diagnostic ability, tissue collection volume, and procedural adverse events of the three‐prong asymmetry tip needle for solid pancreatic, subepithelial, and other organ lesions. Methods We analyzed the data of 58 consecutive patients who underwent endoscopic ultrasound‐guided tissue acquisition using a three‐prong asymmetry tip needle between August 2022 and April 2023 at a single care center. Results The tissue collection rate was 91.4% with 89.7% accuracy, 89.3% sensitivity, 100% specificity, 100% positive predictive value, and 25% negative predictive value. No significant differences in collection rates or diagnostic performance were observed based on the target organ, puncture route, or lesion size. Using our original assessment method, the average histological core tissue score was 3.1 ± 0.8, whereas the blood contamination volume was 2.5 ± 0.8. Only one of 58 patients (1.7%) developed a pancreatic fistula of moderate severity as an adverse event. Conclusions The three‐prong asymmetry tip needle demonstrated good diagnostic capability and adequate sample volume with safety for pancreatic, subepithelial, and other organ lesions.
Year:
2024
Year:
2023
Collaborators (25)
Toshio Fujisawa
Associate Professor
Juntendo University
Shuntaro Mukai
-
Hiroyuki Isayama
-
Hironari Kato
-
Akihisa Ueno
Tokai University
Ichiro Yasuda
Director and Professor
University of Toyama
Kento Shionoya
Tokyo Medical and Dental University
Shomei Ryozawa
-
Mamoru Takenaka
Kindai University Hospital
Hanako Tsujikawa
Keio University Hospital
Yousuke Nakai
University of Tokyo
Saburo Matsubara
Associate Professor
Saitama Medical University
Itaru Naitoh
Nagoya University Graduate School of Medicine
Kenjiro Yamamoto
-
Kazuo Hara
Director
Aichi Cancer Center
Rui Nomura
Keio University
Yoshihide Kanno
Sendai City Medical Center
Ryosuke Tonozuka
-
Yuta Abe
Associate Professor
Keio University
Hiroshi Kawakami
University of Miyazaki
Minoru Kitago
Keio University
Yutaka Kurebayashi
Assistant Professor
Keio University School of Medicine
Hirofumi Kogure
Nihon University School of Medicine
Masayuki Kitano
Professor
Wakayama Medical University
Atsushi Irisawa
Dokkyo Medical University
Make your next move.
Prepare your application
Review drafts before you send them.